Host Respiratory Transcriptome Signature Associated with Poor Outcome in Children with Influenza-Staphylococcus

Carl Britto1,2,3, Irina Mohorianu2,4, Tracy Yeung5

  • 1Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.

Insights

Severe influenza-Staphylococcus aureus coinfection (ISAC) in children is linked to poor outcomes. Reduced host immune gene expression, specifically interferons and related chemoattractants, predicts worse clinical results in ISAC patients.

Area of Science:

  • Microbiology
  • Immunology
  • Genomics

Background:

  • Influenza and Staphylococcus aureus coinfection, particularly with methicillin-resistant S. aureus (MRSA), leads to severe, often fatal, disease in pediatric patients.
  • Understanding the molecular mechanisms of this coinfection is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To identify host and pathogen transcriptomic signatures in the respiratory tract of critically ill children with influenza-S. aureus coinfection (ISAC).
  • To determine if these signatures can predict worse clinical outcomes.

Main Methods:

  • Messenger RNA (mRNA) was extracted from endotracheal aspirate samples of pediatric patients.
  • Evaluated S. aureus virulence genes and host gene expression profiles.
  • Compared transcriptomic data between patients with different coinfection statuses and clinical outcomes.

Main Results:

  • While influenza-MRSA coinfection showed worse outcomes, only 6 of 190 S. aureus virulence genes were differentially expressed between MRSA and methicillin-susceptible S. aureus coinfections, with no predictive value for outcome.
  • Patients with poor outcomes (death or prolonged dysfunction) exhibited reduced expression of interferons and down-regulation of interferon γ-induced immune cell chemoattractants (CXCL10 and CXCL11).
  • Host airway gene expression profiles, not pathogen profiles, predicted worse clinical outcomes in ISAC.

Conclusions:

  • Host transcriptomic signatures in the airway are key predictors of clinical outcomes in pediatric influenza-S. aureus coinfection.
  • Reduced expression of specific host immune genes, including interferons and related chemokines, is associated with severe disease and poor prognosis in ISAC.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
338
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
191
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
299
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
304
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
473
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
213